[Pe-058] English Poster Session 058

[Pe-058-3] Safety and effectiveness of natalizumab: result from 7th year of the post-marketing surveillance

^○Kazumasa Yokoyama¹, Ryusuke Sato², Haruki Makioka², Yuri Al-badri², Michihiro Kanda², Takahiko Saida³ (1.Department of Neurology, Juntendo University School of Medicine, Japan, 2.Biogen Japan Ltd., 3.Kansai Multiple Sclerosis Center, Kyoto Min-iren Central Hospital)